GST- activated anticancer compound used in the treatment of other anti-cancer therapy for the sensitization and / or other improvement of the side effects of cancer treatment

摘要

Mammals, another anti-cancer therapy (ie a human being in particular, chemotherapy, molecular targeted therapy, biological therapy , and anti-cancer treatments, including the non-treatment with radiation therapy, GST- anti-cancer therapy as a treatment with a non-activated anticancer compound, or to each of the sensitized for use in combination and used, or two or more of them) as the sole therapy , or mammal, in particular the use of other active anti-cancer GST- compound in the manufacture of a medicament for improving the side effects of anticancer therapy in humans. Compositions containing GST- activated anticancer compound for the purpose. Sensitized by administration of a sufficient amount of the anticancer compound to the activated GST- mammal sensitive method for solidifying other anti-cancer therapies, especially humans. Improved by administration of a sufficient amount of active anti-cancer compound in GST- to mammal, in particular how to improve the side effect of cancer therapy in humans another. GST- activated anticancer compound is particularly preferably a compound arc U.S. Patent No. 5,556,942 as a hydrogen chloride salt, and more preferably square phosphamid.